.png)
​
Scientific Foundation
The framework, the literature, and the research program behind Psylutions.
From Evidence to Clinical-Grade Care
The science behind psilocybin is no longer speculative. Over two decades of peer-reviewed clinical research, much of it from Johns Hopkins, Imperial College London, NYU Langone, COMPASS Pathways, MAPS, and other institutions, has built a substantive evidence base for psilocybin-assisted therapy in specific indications. What the field still lacks is the manufacturing and dosing rigor needed to translate that evidence into reproducible, regulated clinical care. That is what Psylutions was built to provide.
Why exposure must be measured in milligrams of Total Psychedelic Potency, not grams of biomass.
Learn More
​
The TPP Framework
Why the full alkaloid profile - not psilocybin alone - determines patient response.
Learn More
Pharmacological Signatures™
The conditions Psylutions is actively studying through Healing Center partnerships and observational research. Learn More
Indications Under Study (Pipeline)
Published Studies and Citations
Current peer-reviewed literature on psilocybin in clinical research.
Psylutions actively partners with principal investigators, academic medical centers, and pharmaceutical sponsors. We are now accepting expressions of interest for collaborative observational and interventional research.